drugset / Trial / NCT03154918
GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
This study is to explore the efficacy and safety of GLIDE regiment in patients with aggressive NK/T cell lymphoma.
Timeline
- Start
- 2017-06-01
- Primary completion
- 2020-12-31
- Completion
- 2021-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 20 mg | — |
| Subject | Etoposide | Small molecule | 100 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 800 mg/m2 | — |
| Subject | Ifosfamide | Small molecule | 1000 mg/m2 | — |
| Subject | Pegaspargase | Protein / enzyme biologic | 2500 unknown | — |